Biogen Inc.: UBS raises target price to $270 from $240
BIIB•UBS raised its target price for Biogen to $270 from $240.
Related News
Zedge names Morris Berger CEO effective Oct. 1, 2026
ZDGE•
SMJ International names Li Ailian CFO, director
SMJF•
Pfizer: BofA Global Research raises price objective to $29 from $27
PFE•
Global markets: Oil eases, bringing some respite to stocks and battered bonds
SPY•
Canada's TSX gains after surprise job losses bolster rate-hold outlook
EWC•